Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1999
11/30/1999US5994072 A b-band gene cluster involved in the biosythesis and assembly of lipopolysaccharides; treatment of infections in burn patients, transplants and cystic fibrosis
11/30/1999US5994070 A nucleic acid and polypeptide which regulates a variety of cellular processes; diagnosis and treatment of nervous sytem disorders; alzheimer's/huntinton's/parkinson's diseases
11/30/1999US5994066 Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
11/30/1999US5994062 Detecting messenger rna encoding a heterogeneous nuclear ribonucleoprotein peptide by isolating epithial cells, mixing rna from the cells with a probe encoding a marker protein, forming a hybridization product in an immunoassay kit
11/30/1999US5994060 Gro genes, proteins, and uses thereof
11/30/1999US5994055 HIV trans-activator Tat binding to CDK7 and activation of CTD phosphorylation
11/30/1999US5994054 Creating an expression library, transfecting cells with a dna molecule which contains a long terminal repeat promoter sequence of human immunodeficiency virus adjacent to a reporter molecule, measuring viricide activity
11/30/1999US5994053 Phragmoplastin and methods of examining cell plate development
11/30/1999US5993829 Anti-cancer vaccine
11/30/1999US5993828 Administering to the subject an effective dose of a composition comprising inactivated tumor cells having urinary tumor associated antigen on the cell surface and at least one tumor associated antigen
11/30/1999US5993827 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
11/30/1999US5993826 Relates generally to various outer membrane proteins (omps) of moraxella catarrhalis for use as targets in immunotherapy
11/30/1999US5993825 Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
11/30/1999US5993824 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
11/30/1999US5993823 Cytotoxic T lymphocyte-inducing lipopeptides and methods of use
11/30/1999US5993821 Antigens and vaccines containing said vlps that may be effective in treatment of infections caused by such viruses.
11/30/1999US5993820 The antigenic sequence is inserted into the ltb molecule by inserting the gene encoding the inhibin fragment into etxb at the unique sma i restriction site.
11/30/1999US5993819 Amino acid sequences corresponding to antigenic determinants of the envelope glycoprotein of hiv, covalently coupled, directly or through a spacer molecule, to carrier molecules suitable for vaccination of mammals.
11/30/1999US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999US5993814 Agents for inhibition of chemoattractant
11/30/1999US5993808 Chitinase, DNA coding therefor and plants containing same
11/30/1999US5993803 Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
11/30/1999US5993801 Gene therapy using stromal cells
11/30/1999US5993800 Methods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligand
11/30/1999US5993799 Methods of using genetically engineered cells that produce insulin in response to glucose
11/30/1999US5993798 Treatment of carcinoma and lymphoma.
11/30/1999US5993775 Peptides which bind technetium or rhenium and which can be targeted to specific sites within a mammalian body.
11/30/1999CA2129823C Myotonic dystrophy
11/30/1999CA2128250C Insecticidally effective peptides
11/30/1999CA2030795C Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
11/30/1999CA2019035C Stabilized radiopharmaceutical compositions
11/30/1999CA1340834C Derivatives of human/bovine basic fibroblast growth factor
11/30/1999CA1340832C Recombinant cmv neutralizing proteins
11/30/1999CA1340830C Process for production of physiologically active peptide containing cysteine residue
11/25/1999WO1999060407A1 Assays, methods and means for modulating e2f activity
11/25/1999WO1999060405A1 Method for diagnosis and treatment of cancer
11/25/1999WO1999060400A1 Bis-biotin compounds for specific binding assays
11/25/1999WO1999060171A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999WO1999060164A1 Mechanical stress induced genes, expression products therefrom, and uses thereof
11/25/1999WO1999060153A2 Novel g-protein coupled receptor
11/25/1999WO1999060150A1 Method for catalysing complex reactions of large molecules using enzymes which are bonded to a polymer support
11/25/1999WO1999060149A1 Co-precipitates of adenovirus with metal salts
11/25/1999WO1999060148A2 Display of viral proteins as ligands for cell-surface receptor
11/25/1999WO1999060146A1 Adeno-associated virus vectors and uses thereof
11/25/1999WO1999060144A1 Methods and compositions for producing viral particles
11/25/1999WO1999060141A1 Genes and methods for control of nematodes in plants
11/25/1999WO1999060136A1 Methods for producing polypeptides in filamentous fungal mutant cells
11/25/1999WO1999060135A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases
11/25/1999WO1999060132A1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/25/1999WO1999060131A2 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
11/25/1999WO1999060130A1 Expression of recombinant trypanosoma cruzi complement regulatory protein (crp)
11/25/1999WO1999060128A1 Il-2 selective agonists and antagonists
11/25/1999WO1999060127A2 Il-17 homologous polypeptides and therapeutic uses thereof
11/25/1999WO1999060126A2 Protein z-dependent protease inhibitor
11/25/1999WO1999060125A2 Secreted proteins
11/25/1999WO1999060124A2 Differentiation-associated sequences and methods of use therefor
11/25/1999WO1999060123A1 Methods and compositions for hdl holoparticle uptake receptor
11/25/1999WO1999060122A1 Method for examining central nervous system diseases and method for screening remedies
11/25/1999WO1999060121A1 Metabotropic glutamate receptor-like protein and encoding cdna
11/25/1999WO1999060120A2 Soluble t cell receptor
11/25/1999WO1999060119A2 Multivalent t cell receptor complexes
11/25/1999WO1999060118A1 GABAA RECEPTOR ε2 SUBUNIT
11/25/1999WO1999060117A2 Prax-1 polypeptide
11/25/1999WO1999060116A1 Nucleic acid encoding protein, down-regulated in metastasis (drim), and its diagnostic and therapeutic use
11/25/1999WO1999060115A2 Proteins and genes useful as tumor markers
11/25/1999WO1999060114A1 Insect control gene dsf and methods of use
11/25/1999WO1999060113A1 Novel method for isolating gene
11/25/1999WO1999060110A2 Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy
11/25/1999WO1999060109A2 Soybean gene promoters
11/25/1999WO1999060108A2 Transgenic animals produced by homologous sequence targeting
11/25/1999WO1999060106A2 A universal plant promoter inducible by low- temperatures
11/25/1999WO1999060101A1 Isolated stealth viruses and related vaccines
11/25/1999WO1999060099A1 Amino acid modified polypeptides
11/25/1999WO1999060022A1 Calcium channel regulators
11/25/1999WO1999060021A2 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system
11/25/1999WO1999060020A1 Secreted proteins and polynucleotides encoding them
11/25/1999WO1999060019A1 HUMAN EDG3sb GENE
11/25/1999WO1999060018A1 Labelled glutamine and lysine analogues
11/25/1999WO1999060017A2 Human tumour-derived polypeptide hormone phosphatonin
11/25/1999WO1999060016A2 Antimicrobial cationic peptide derivatives of bactenecin
11/25/1999WO1999060014A2 Methods and compounds for modulating nuclear receptor coactivator binding
11/25/1999WO1999060013A2 Il-6 antagonist peptides
11/25/1999WO1999059796A1 Bioriented polyethylene film with a high water vapor transmission rate
11/25/1999WO1999059631A1 Prevention and treatment of hypergastrinemia
11/25/1999WO1999059630A1 Type iii bordetella secretion system
11/25/1999WO1999059627A2 Verotoxin b subunit for immunization
11/25/1999WO1999059625A1 Vaccine delivery system
11/25/1999WO1999059620A1 Angiostatin receptor
11/25/1999WO1999059619A1 Acrp30r1: a homolog of acrp30 (30 kd adipocyte complement-related protein)
11/25/1999WO1999059618A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein)
11/25/1999WO1999059617A2 Immunoregulator
11/25/1999WO1999059615A1 Hybrid polypeptides with enhanced pharmacokinetic properties
11/25/1999WO1999059613A1 BINDING MOIETIES FOR UROKINASE PLASMINOGEN ACTIVATOR (uPA)
11/25/1999WO1999059609A2 Use of hmg proteins for the preparation of medicaments having cytotoxic activity
11/25/1999WO1999059608A2 Osteoporosis treatment
11/25/1999WO1999059565A1 Novel compositions
11/25/1999WO1999059560A1 Glucose transport modulators and uses therefor
11/25/1999WO1999059559A1 Independent regulation of basal and insulin-stimulated glucose transport
11/25/1999WO1999059412A1 Biocontrol agent and pesticide
11/25/1999WO1999050301A3 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
1 ... 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 ... 2916